Insulin Human
Type 2 Diabetes
Cairo UniversityPhase 4 / ApprovedDormant
B
59/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 73/ 100
Competitive context
56 Active assets in the Type 2 Diabetes cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Semaglutide Shanghai Jiao Tong University School of Medicine | Phase 4 | BBB |
Liraglutide RenJi Hospital | Phase 4 | BBB |
Pioglitazone Seoul National University Bundang Hospital | Phase 4 | BBB |
Empagliflozin Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 | BBB |
Tirzepatide Las Rías Medical Center | Phase 4 | BB |
View all 50 →
Same molecule, other indications
Insulin Human is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →